Clinical Trial

Evaluation of the Safety and Efficacy of Dehydrated Human Placenta Tissue (dHPT) for Wound Healing

Study acronym: RETRO-PLAST
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The retrospective trial is observational, intended to stand alone, complement and integrate data collected in ongoing clinical studies to aid in establishing payor coverage in the United States (U.S.) for Cellution Biologics allograft products with real-world evidence to support the clinical adoption in patients to manage chronic or surgical wounds.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-21.
Trial Details
NCT Number NCT07375160
Lead Sponsor Cellution Biologics
Conditions Diabetic Foot Ulcer (DFU), Venous Leg Ulcer (VLU), Pressure Ulcer (PU)
Enrollment 300 participants
Start Date 2026-04
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-03